Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
BIO Statement on the Section 232 Pharmaceutical…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO), released the following statement on Section 232 Pharmaceutical Proclamation.“A thriving American biotechnology ecosystem is essential to…
Learn more
BIO Statement on Passage of Legislation…
WASHINGTON, D.C. - Brad Zakes, senior vice president for emerging companies and economic affairs at the Biotechnology Innovation Organization (BIO), released the following statement on passage of legislation reauthorizing the SBIR/STTR program:"The…
Learn more
Announcing Investor Connect Plus: A LaunchBio x…
Accelerating Growth Through ConnectionsLaunchBio and the Biotechnology Innovation Organization (BIO) today announced the launch of Investor Connect Plus, an exclusive, BIO member-only investor access program designed for established, capital-ready…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
New Season of “I am BIO” Podcast Explores Patient Stories, Weight Loss Drugs, Food Security, and More
September 5, 2024
WASHINGTON - (September 5, 2024) –The Biotechnology Innovation Organization (BIO) will launch the fall season of the award-winning “I am BIO” podcast on September 10. Now entering its fifth year, the podcast explores the intersection of…
BIO Statement On Selected Drugs in Medicare under Inflation Reduction Act
August 15, 2024
The Biotechnology Innovation Organization (BIO) released the following statement after today’s announcement from the Centers for Medicare & Medicaid Services (CMS) on selected drugs under the Inflation Reduction Act (IRA):“While the Inflation…
Sylvia Wulf to Serve as Interim Lead of BIO's Agriculture & Environment Center of Excellence
July 25, 2024
WASHINGTON, D.C., July 25, 2024—Today, the Biotechnology Innovation Organization (BIO) announced the appointment of longtime biotechnology executive Sylvia Wulf to lead the Agriculture & Environment Center of Excellence (AECOE). The AECOE…
BIO Commends FDA Plan to Establish a Rare Disease Innovation Hub to advance rare disease collaboration, treatments
July 17, 2024
July 17, 2024 – BIO President and CEO John F. Crowley today released the following statement after the U.S. Food & Drug Administration (FDA) announced a plan to establish a Rare Disease Innovation Hub that will utilize new and collaborative…
BIO Applauds Introduction of Bipartisan Legislation to Reauthorize Program That Encourages Rare Pediatric Disease Research
June 20, 2024
BIO President and CEO John F. Crowley today released the following statement after a bipartisan group of Senators, Sen. Bob Casey (D-PA), Sen. Markwayne Mullin (R-OK), Sen. Sherrod Brown (D-OH), and Sen. Susan Collins (R-ME), introduced the Creating…
BIO International Convention Celebrates Another Successful Year as Biotech Industry’s Largest and Most Influential Event
June 10, 2024
Biotechnology Innovation Organization (BIO) is proud to conclude the 2024 BIO International Convention in San Diego, held last week June 3-6, 2024. 1,400 exhibitors and more than 19,500 attendees from 70 countries came together for four full days of…
BIO Recognizes Industry Leaders for Groundbreaking Work in Agricultural, Environmental Biotech
June 5, 2024
WASHINGTON - June 5, 2024 – The Biotechnology Innovation Organization (BIO) today announced the winners of the organization’s 2024 Leadership in Agri-Biotechnology Awards — honoring Dr. Annette Kleiser, CEO of Dalan Animal Health, as the recipient…
More than 8 in 10 Biotech Companies Rate DEI as Important Area of Strategic Focus, according to New Report from BIO and Korn Ferry
June 4, 2024
WASHINGTON - June 4, 2024 – The Biotechnology Innovation Organization (BIO), in partnership with Korn Ferry, today released a new survey assessing diversity, equity, and inclusion (DEI) in the biotechnology industry. The report, “Charting a Path to…
Viola Davis, Acclaimed Actress and Producer with Award-winning Journalist Brooke Baldwin Take Center Stage at BIO International Convention
May 23, 2024
WASHINGTON - (May 23, 2024) – Viola Davis, award-winning actress and producer, will discuss “The Convergence of Entrepreneurship and Innovation” with award-winning journalist and bestselling author Brooke Baldwin at the 2024 BIO International…
New BIOSECURE bill "reinforces the national security imperative of the biotechnology industry"
May 9, 2024
House lawmakers today unveiled a new draft of the BIOSECURE Act. Shortly after, BIO President and CEO, John F. Crowley, made the following statement: "The BIOSECURE bill released in the House today reinforces the national security imperative of the…